Tag Archives: NK cells

Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Posted on 02/23/2022 by wames

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients, by Natalie Eaton-Fitch, Stanley Du Preez, Hélène Cabanas, Katsuhiko Muraki, Donald Staines & Sonya Marshall-Gradisnik in Journal of Translational Medicine volume 20, … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Treatment research: …restoration using Naltrexone in natural killer cells of ME/CFS patients

Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Posted on 11/15/2021 by wames

Characterization of IL-2 stimulation and TRPM7 pharmacomodulation in NK Cell cytotoxicity and channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome patients, by Stanley Du Preez , Natalie Eaton-Fitch, Helene Cabanas, Donald Staines and Sonya Marshall-Gradisnik in Int. J. … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: The characterization of IL-2 stimulation & treatment of TRPM3… in ME/CFS

Impact of long-term cryopreservation on blood immune cell markers in ME/CFS: implications for biomarker discovery

Posted on 12/11/2020 by wames

Impact of long-term cryopreservation on blood immune cell markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: implications for biomarker discovery, by Elisabet Gómez-Mora,  Jorge Carrillo,  Víctor Urrea,  Josepa Rigau,  José Alegre,  Cecilia Cabrera,  Elisa Oltra,  Jesús Castro-Marrero and  Julià Blanco in Front. … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Impact of long-term cryopreservation on blood immune cell markers in ME/CFS: implications for biomarker discovery

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Posted on 10/31/2019 by wames

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, by Helene Cabanas,  Katsuhiko Muraki,  Donald Staines and Sonya Marshall-Gradisnik in Front. Immunol., 31 October 2019 [https://doi.org/10.3389/fimmu.2019.02545]   Research … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Posted on 05/21/2019 by wames

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients, by H Cabanas, K Muraki, C Balinas, N Eaton-Fitch, D Staines, S Marshall-Gradisnik in Mol Med. 2019 Apr … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Cellular immune function in ME/CFS: increased MAIT cell frequency

Posted on 04/17/2019 by wames

Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), by Jacqueline M Cliff, Elizabeth C King, Ji-Sook Lee, Nuno Sepulveda, Asia-Sofia Wolf, Caroline Kingdon, Erinna Bowman, Hazel M. Dockrell, Luis C. Nacul, Eliana Lacerda, Eleanor Riley in Front. Immunol., 16 April … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Cellular immune function in ME/CFS: increased MAIT cell frequency

Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME

Posted on 08/29/2018 by wames

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from CFS/ME patients by Hélène Cabanas, Katsuhiko Muraki, Natalie Eaton, Cassandra Balinas, Donald Staines and Sonya Marshall-Gradisnik in Molecular Medicine 2018 24:44 [Published: 14 August 2018] Research abstract: … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME

Reduced glycolytic reserve in isolated natural killer cells from ME/CFS patients

Posted on 07/20/2018 by wames

Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/ chronic fatigue syndrome patients: A preliminary investigation, by Thao Nguyen, D Staines, S Johnston, S Marshall-Gradisnik in Asian Pac J Allergy Immunol. 2018 Jul 8. [Epub ahead of print] … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Reduced glycolytic reserve in isolated natural killer cells from ME/CFS patients

Association of T & NK cell phenotype with the diagnosis of ME/CFS

Posted on 05/16/2018 by wames

Research abstract: Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), by Jose Luis Rivas, Teresa Palencia, Guerau Fernández, Milagros Garcia in Front. Immunol., 09 May 2018 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Association of T & NK cell phenotype with the diagnosis of ME/CFS

Rituximab impedes natural killer cell function in CFS/ME patients

Posted on 03/28/2018 by wames

Research abstract: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation by Natalie Eaton, Hélène Cabanas, Cassandra Balinas, Anne Klein, Donald Staines and Sonya Marshall-Gradisnik in BMC Pharmacology and Toxicology 2018 19:12 [Published: … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Rituximab impedes natural killer cell function in CFS/ME patients